MC1476A1 - Derives de la pyrrolidine - Google Patents

Derives de la pyrrolidine

Info

Publication number
MC1476A1
MC1476A1 MC821598A MC1598A MC1476A1 MC 1476 A1 MC1476 A1 MC 1476A1 MC 821598 A MC821598 A MC 821598A MC 1598 A MC1598 A MC 1598A MC 1476 A1 MC1476 A1 MC 1476A1
Authority
MC
Monaco
Prior art keywords
formula
hydrogen
useful
pyrrolidine derivatives
iii
Prior art date
Application number
MC821598A
Other languages
English (en)
French (fr)
Inventor
Werner Aschwanden
Emilio Kyburz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH4849/81A external-priority patent/CH647234A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1476A1 publication Critical patent/MC1476A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
MC821598A 1981-07-24 1982-07-22 Derives de la pyrrolidine MC1476A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4849/81A CH647234A5 (en) 1981-07-24 1981-07-24 Pyrrolidine derivatives
CH276882 1982-05-05

Publications (1)

Publication Number Publication Date
MC1476A1 true MC1476A1 (fr) 1983-06-17

Family

ID=25691358

Family Applications (1)

Application Number Title Priority Date Filing Date
MC821598A MC1476A1 (fr) 1981-07-24 1982-07-22 Derives de la pyrrolidine

Country Status (34)

Country Link
US (3) US4476308A (xx)
EP (1) EP0071216B1 (xx)
AT (2) AT384424B (xx)
AU (1) AU557651B2 (xx)
BG (1) BG38334A3 (xx)
CA (1) CA1176251A (xx)
CS (1) CS226746B2 (xx)
DD (1) DD202540A5 (xx)
DE (2) DE3227649A1 (xx)
DK (1) DK157848C (xx)
EG (1) EG15921A (xx)
ES (1) ES514267A0 (xx)
FI (1) FI75158C (xx)
FR (1) FR2515179A1 (xx)
GB (2) GB2110207B (xx)
HK (1) HK53788A (xx)
HU (1) HU187777B (xx)
IE (1) IE53428B1 (xx)
IL (1) IL66341A (xx)
IT (1) IT1152287B (xx)
LU (1) LU84294A1 (xx)
MC (1) MC1476A1 (xx)
MT (1) MTP915B (xx)
NL (1) NL8202922A (xx)
NO (1) NO159592C (xx)
NZ (1) NZ201297A (xx)
OA (1) OA07151A (xx)
PH (1) PH19149A (xx)
PT (1) PT75314B (xx)
RO (1) RO84097B (xx)
SE (1) SE8204445L (xx)
SG (1) SG22788G (xx)
SU (1) SU1281172A3 (xx)
ZW (1) ZW14482A1 (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
IT1206699B (it) * 1984-02-27 1989-04-27 Isf Spa Procedimento per preparare derivati di pirrolidone.
IT1173763B (it) * 1984-03-30 1987-06-24 Proter Spa Derivati dell'acido 3-mercapto-2-oxo-1-pirrolidinacetico,procedimento di preparazione e composizioni farmaceutiche che li contengono
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
US4758585A (en) * 1985-08-16 1988-07-19 Warner-Lambert Company Saturated cycloalkyl (B) pyrrol-1 (2H)- acetic acid amides and derivatives thereof
IT1224168B (it) * 1986-08-01 1990-09-26 Finanziaria R F Spa Ora Finanz Derivati del pirrolidin-2-one ad attivita' nootropa
CA1322199C (en) * 1987-07-15 1993-09-14 Masami Eigyo N-¬(2-oxopyrrolidin-1-yl) acetyl)| piperazine derivatives and drug for senile dementia
JPS6422883A (en) * 1987-07-17 1989-01-25 Sanwa Kagaku Kenkyusho Co 1-pyrrolidine acetamide derivative, its salt, production thereof and prophylactic and remedial agent for cereral dysfunction containing said derivative and salt as active ingredient
DE3813416A1 (de) * 1988-04-21 1989-11-02 Hoechst Ag 3,4-dihydroxypyrrolidin-2-on-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
EP0440789A1 (de) * 1988-04-22 1991-08-14 2-i MOSKOVSKY GOSUDARSTVENNY MEDITSINSKY INSTITUT IMENI N.I. PIROGOVA Carbalkoxymethylether von lactam-1-essigsäure sowie herstellungsverfahren
IT1245870B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti 3-acilammino-2-pirrolidinoni quali attivatori dei processi di appremdimento e della memoria e composizioni farmaceutiche comprendenti tali composti
DE4127404A1 (de) * 1991-08-19 1993-02-25 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA2100641A1 (en) * 1992-07-23 1994-01-24 Hiromu Matsumura Novel piperidine derivatives and process for preparation thereof
US5679798A (en) * 1996-11-22 1997-10-21 Mona Industries, Inc. Silicone monomers having a carboxyl functional group thereon
EP0951468A4 (en) * 1996-11-22 2001-06-06 Mona Industries Inc SILICONE MONOMERS AND OLIGOMERS CONTAINING A CARBOXYL FUNCTIONAL GROUP
US6686477B2 (en) 2000-09-29 2004-02-03 Eastman Chemical Company Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
DK3260118T3 (da) * 2008-10-16 2021-04-19 Univ Johns Hopkins Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion
CA2789014C (en) * 2010-02-09 2019-01-15 Michela Gallagher Methods and compositions for improving cognitive function
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
CA2904767C (en) 2013-03-15 2022-06-21 Agenebio, Inc. Methods and compositions for improving cognitive function
WO2016191288A1 (en) 2015-05-22 2016-12-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
GB1309692A (en) * 1970-02-13 1973-03-14 Ucb Sa N-substituted lactams
IT1045043B (it) * 1975-08-13 1980-04-21 Isf Spa Derivati pirrolidinici
IT1075564B (it) * 1977-02-11 1985-04-22 Isf Spa Procedimento per la preparazione di derivati pirrolidinici
IT1075280B (it) * 1977-02-11 1985-04-22 Isf Spa Procedimento per la preparazione di derivati pirrolidinici
BE864269A (fr) * 1977-03-03 1978-06-16 Parke Davis & Co Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire
IT1141287B (it) * 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
DE2923975A1 (de) * 1979-06-13 1980-12-18 Nattermann A & Cie Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE2924011C2 (de) * 1979-06-13 1982-04-08 A. Nattermann & Cie GmbH, 5000 Köln Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten
IT1131959B (it) * 1979-08-09 1986-06-25 Hoffmann La Roche Derivati pirrolidinici
CH657527A5 (de) * 1980-02-13 1986-09-15 Ciba Geigy Ag Verwendung von zentralnervoes-wirksamen verbindungen in einem mittel, welches zur verhinderung oder linderung von nebenwirkungen bestimmt ist.
US4372960A (en) * 1980-12-12 1983-02-08 Warner-Lambert Company Quaternary derivatives of N-(substituted-aminoalkyl)-2-oxo-1-pyrrolidine-acetamides as cognition activators
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
BE892942A (fr) * 1982-04-23 1982-10-25 Ucb Sa Procede pour prevenir ou attenuer les psychoses iatrogenes causees par les medicaments a activite cytostatique.

Also Published As

Publication number Publication date
NO159592B (no) 1988-10-10
IE53428B1 (en) 1988-11-09
GB2152038A (en) 1985-07-31
US4650878A (en) 1987-03-17
GB8426076D0 (en) 1984-11-21
EP0071216A2 (de) 1983-02-09
FI75158B (fi) 1988-01-29
SG22788G (en) 1988-07-15
FI75158C (fi) 1988-05-09
MTP915B (en) 1985-12-28
DE3274851D1 (en) 1987-02-05
HU187777B (en) 1986-02-28
IT8222335A1 (it) 1984-01-09
US4476308A (en) 1984-10-09
AU557651B2 (en) 1987-01-08
IL66341A0 (en) 1982-11-30
US5034402A (en) 1991-07-23
LU84294A1 (de) 1984-03-22
DK157848B (da) 1990-02-26
FI822543A0 (fi) 1982-07-19
GB2110207A (en) 1983-06-15
ES8307743A1 (es) 1983-08-16
CA1176251A (en) 1984-10-16
DE3227649A1 (de) 1983-02-10
US4476308B1 (xx) 1987-03-10
IT8222335A0 (it) 1982-07-09
RO84097B (ro) 1984-06-30
FR2515179A1 (fr) 1983-04-29
ZW14482A1 (en) 1983-02-09
SE8204445L (sv) 1983-01-25
AT384424B (de) 1987-11-10
SU1281172A3 (ru) 1986-12-30
DD202540A5 (de) 1983-09-21
PH19149A (en) 1986-01-15
NL8202922A (nl) 1983-02-16
AU8615882A (en) 1983-01-27
PT75314B (en) 1985-11-29
GB2110207B (en) 1985-09-04
RO84097A (ro) 1984-05-12
DK157848C (da) 1990-07-23
NO159592C (no) 1989-01-18
EP0071216B1 (de) 1986-12-30
HK53788A (en) 1988-07-22
IE821768L (en) 1983-01-24
ATA286382A (de) 1987-04-15
BG38334A3 (en) 1985-11-15
PT75314A (en) 1982-08-01
SE8204445D0 (sv) 1982-07-23
EG15921A (en) 1986-09-30
DK317382A (da) 1983-01-25
GB2152038B (en) 1986-01-02
CS226746B2 (en) 1984-04-16
ATE24488T1 (de) 1987-01-15
EP0071216A3 (en) 1983-09-07
IL66341A (en) 1986-12-31
IT1152287B (it) 1986-12-31
FR2515179B1 (xx) 1985-01-18
FI822543L (fi) 1983-01-25
NZ201297A (en) 1985-12-13
OA07151A (fr) 1984-03-31
NO822222L (no) 1983-01-25
ES514267A0 (es) 1983-08-16

Similar Documents

Publication Publication Date Title
US4476308B1 (xx)
DK142985D0 (da) Redox-indikatorer
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
NZ216048A (en) Quinolylglycinamide derivatives, and pharmaceutical compositions containing such
ATE18228T1 (de) Neue thieno-thiazol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
SE8903312D0 (sv) New 2-carbonyl substituted n,n'-di-(trimethoxybenzol)piperazines, process for preparing the same and therapeutical compounds containing them
ES2062214T3 (es) Derivados de aminooligohidroxi inhibidores de renina.
NO904708D0 (no) Fremgangsmaate for fremstilling av derivater av 2-(3-pyridyl)-2-tetrahydrotiopyrankarbotioamid-1-oksid-(1r-2r).
ATE87004T1 (de) Fluor enthaltende makrolid-verbindungen, pharmazeutische zusammensetzungen, welche diese enthalten und ihre verwendung fuer die herstellung von arzneimitteln.

Legal Events

Date Code Title Description
YP Annual fee paid